MODEL VERDICT
Planet Labs PBC (PL)
Relative Valuation•Peer multiples, competitive benchmarking & quality-adjusted fair value
The market is pricing Planet Labs PBC at a 68% premium to its peer-implied fair value.
19 industry peers matched by industry sector due to narrow curated coverage
| Ticker | Company | Market Cap | P/E | EV/EBITDA |
|---|---|---|---|---|
| GE | GE Aerospace | $373.67B | 43.83x | 38.22x |
| RTX | RTX Corporation | $249.94B | 37.42x | 21.88x |
| BA | The Boeing Company | $175.57B | 89.81x | - |
| LMT | Lockheed Martin Corporation | $117.75B | 23.78x | 16.03x |
| GD | General Dynamics Corporation | $94.65B | 22.64x | 16.92x |
| TDG | TransDigm Group Incorporated | $75.01B | 41.41x | 22.56x |
| NOC | Northrop Grumman Corporation | $74.07B | 17.93x | 15.54x |
| LHX | L3Harris Technologies, Inc. | $55.07B | 34.56x | 18.85x |
| HEI | HEICO Corporation | $46.96B | 68.8x | 40.28x |
| ESLT | Elbit Systems Ltd. | $36.91B | 69.2x | 43.38x |
| AXON | Axon Enterprise, Inc. | $34.11B | 280.4x | 1651.54x |
| CW | Curtiss-Wright Corporation | $28.49B | 59.98x | 46.13x |
1 valuation metric · peer-median based
| Multiple | Current | Peer Median | vs Peers | Implied Price |
|---|---|---|---|---|
| P/FCFPrice paid for free cash flow. | 163.02x | 46.37x | Premium +251.53% | $8.69 |
How the model derives the final fair value from peer baselines and quality metrics
Premium: The stock is trading at a 212.36% premium to its quality-adjusted fair value of $9.04. The market is pricing the stock 67.99% above our model's estimate.
Quality metrics are broadly comparable to peers.
Quality adjustments are capped at ±15% (up to ±20% for financial services) to prevent runaway premiums. Based on trailing twelve months and multi-year CAGR data where available.
How current multiples rank vs 1 years of the stock’s own history
| Multiple | Current | Historical Median | Percentile | Status |
|---|---|---|---|---|
| P/FCF1 years of data | 163.02x | 133.32x | 100th | Above historical norm |
Planet Labs PBC currently trades near the highest valuation levels observed during the last 1 years.
Wall Street target prices — 22 analysts
Model-identified caveats to consider
PL has a limited relative valuation using L2 rescue peers after thin AI peer data; based mainly on P/FCF, it looks expensive versus peers.
Answers to common questions about PL's relative valuation and our methodology.
Planet Labs PBC's fair value of $9.03 is the price at which the stock would trade if valued at the same multiples as its 19-company peer group, adjusted for differences in business quality. At $28.23, the stock trades at a -68.01% premium to fair value. This is a reference point, not a price target.
Peers were grouped by industry classification and market capitalization. The 19 companies shown are the closest comparable names with clean, usable financial data.
Planet Labs PBC has strengths in 3y revenue growth, fcf margin, and challenges in roic, and a quality score that justifies a 4% premium relative to its peer group. The Quality Adjustment section breaks down each driver.
No. This page provides an automated quantitative comparison of Planet Labs PBC against its peers. It is not investment advice, a recommendation, or a solicitation. Valuation is only one factor in an investment decision — it does not account for growth catalysts, management quality, regulatory risk, or your personal financial situation.
A 68.01% premium is substantial. Large premiums suggest the market is pricing in significant growth or quality advantages that must be delivered to justify the current price. Review the Risk Factors and Historical Context sections to assess whether the gap is justified.
Valuation data is refreshed weekly based on the latest financial filings, market prices, and analyst estimates. Planet Labs PBC's fair value, peer multiples, and quality scores will shift over time as new earnings are reported and stock prices change.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. Fair value estimates are model outputs under stated assumptions and should not be relied upon as the sole basis for any investment decision.